News & Articles

Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines

A revolutionary advancement in X-ray photoelectron spectroscopy depth profiling

Highly complementary technologies strengthen Thermo Fisher’s portfolio in bioprocessing and adjacent markets

Next-generation HEK293 transient expression system is driving breakthroughs in therapeutic development

Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS (zongertinib tablets), the first and only orally administered targeted treatment for HER2 (ERBB2)-mutant NSCLC

Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field

New solution delivers high-integrity DNA exceeding 100 kb in under two hours, supporting automation across KingFisher platforms to accelerate long-read sequencing research

To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance

The comprehensive portfolio advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis

New assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results

Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions

As part of the agreement, Thermo Fisher will manage the sales, distribution, and customer support for Massbox in Europe and China

Strategic collaboration to innovate Treg and TIL therapies, streamline cell therapy workflows, and enhance manufacturing efficiency

New research shows integrated services can reduce Phase I-III study times by up to nearly three years, generating strong ROI for biotech and biopharma customers

The Vanquish CAD P Series helps laboratories achieve reliable results faster to drive performance, confidence and convenience in daily analytical testing

New analytical instruments and innovative software to drive breakthroughs in biopharmaceutical discovery, translational omics and safer water quality

Orbitrap Astral Zoom and Orbitrap Excedion Pro deliver increased speed and sensitivity to set a new performance benchmark for high-resolution, accurate mass spectrometry

Researchers can obtain deeper insights from cells with more colors and faster time to results with minimal sample volume

Designed to enable scientists to conduct small-scale experiments quickly and affordably

Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization

First-of-its-kind bench scale bioreactor enabling productivity, scalability and efficiency supporting reduced environmental impact

The new Krios 5 Cryo-TEM enables breakthroughs in structural and cellular biology to pioneer new treatments and advance drug discovery

The new genetic analyzer supports both clinical as well as research for Sanger sequencing and fragment analysis in targeted genomic testing